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Is the cytosolic catalase induced by peroxisome proliferators in mouse 
liver on its way to the peroxisomes? 
Rcccivcd IS June 1992 
Dietary trcutmcnt of male C57D116 mice with clofibntc, nafcnopin or WY-14.643 rcsultcd in II modest (ut most 2.fold)incrcrr in the totolatalare 
activity in the whole homogcnntc und mitochondrial fraction prcpvrcd from the livcrn of thcsc rnimulr. On thr othrr hand, the utalasc activity 
recovcrcd in the cytosolic faction was incrcascd I 2. to Iti-fold, i.e. j&3%6 of the toul wtnlrrsc activity in the hcpntic homot(cnate was present 
in the high-spad I;upcrnul;lnt fruction after trcatmcnt with thsrc pcroxisomc prolifcraaors. A study of the time course of the changes in pcronisomal 
and cytoralic cut&se uctivitie* dcmonstnrlsd thnt the pcroxiromel activity boll1 incrcamcd upon initiation of cxpoaurc and dccrcarcl vkr 
termination of trcatmcnt ccvcrnl duys uftcr the increase und dccrcusc. rcspcctivcly, in the rorrcspondin~ cytorolic activity. This tinding ru~gnis 
thrt the cytorolic wtalaric may bc on its way to incorporation into pcroxisomer. 
Cntulusc; Pcraxisomc prolifcralion; Clotibmtc: Nafcnopin; WY-14.643: Liver; Mouse 
1. INTRODSJCTION 
Despite tnttny years of study, there is still u great dctrl 
of controversy concerning the subcellular lossliwtion 
of catnltrsc (which plays un important role in the dctox- 
ication of H& by transforming this reactive oxygen 
spccics to water) in murnmulian cells (e.g. [ 1 ,?I). Cm- 
10s~ isthought to be primarily localized in praxiaomss. 
but there arc also numerous indications that a small 
portion of the total activity may also be present in the 
cytoplasm undti ilormal physiological condition-s (c.g, 
[l.3-61)s 
After trcotmcnt of rodents with certain pcraxisomc 
prolifcmtors, \4c catnlasc activity in the high-speed su- 
permutant (sytosolis) fraction from the liver hus been 
found to bc increased (e.g. [1,7-9]), 
It has been argued that this incrcasc reflects leakage 
from pcroxisomcs during the subfractionation prosc- 
durc [lo] and a11 inniunocytoshcmical analysis con- 
cluded that catttlase is entirely losalirscd in the pcr- 
oxisomcs of mouse hcpntosytcs, both without and after 
treatment with clofibrate [111. The criticism of the latter 
study is thut the total volume of the pcroxisomes is 
much srnallcr than that of the cytoplasm and that there 
might therefore be P much higher conccntrntion of cat- 
alasc in the pcroxisorncs, which would thus appear to 
contain all of this enzyme. In addition, when WC pcrmc- 
abilizcd the plasma membrane of isolated mouse hepat- 
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ocytcs with digitonin under conditions which left intra- 
ccllultlr orguncltcs intact, S-IO% of the total cetular in 
control sells und 3mO% of this activity in hcpircocytcs 
from clofibrotc-treated animels WLLS rclcescd to the sur- 
rounding medium [9]. 
Therefore, it is our working hypothesis that pcr- 
oxisomc prolifcrutors selectively insrcess the cytosolis 
content of czttulasc in mouse hcpatocytcs. The object of 
the prcscnt study was to churrrctcrizs this increase by 
clofibratc, nafcnopin and WY-14.643 in more dctuil. In 
addition, the time-course of changes in catalase upon 
treatment with clofibrate and subscqucnt termination of 
this exposure were investigated in order to dctcrrninc 
whether there wits u tcmporul ‘precursor-product’ rcln- 
tionship between cytosolic und pcroxisomol satalose in 
this system. 
2. EXPERIMENTAL 
2.1, Citnrliclllx 
Clofibratc (ethyl p~hlorophcnoxyisobutyratc) (ICI, Macclcsficld. 
Chcrhirc, Englnnd) sad hydrogen peroxide (30%) (E. Merck. Darm- 
stndt, Gcrmimy) wcrc purchnscd from the ~ourccs indicutcd. Nafcno- 
pin (?-mcthyl-2~(1.2.3.4-tctrahydro-1-nnplrthyl~phcnoxy)proprion- 
ic ucid) (Dr, Chlrrlcs A. BrownIcy, CIBA Phurmaccutic;ll Do,, Som- 
mit, NJ, USA) und WY-14543 (4-chlorsd-(2.3- xylidino)?-pyrimid- 
inyl-thio)xcticncid)(Ms, Klry Mnrlcy. Wyeth LubontoriaInc.. Phil- 
tidclphiu. PA, USA) wcrc kind gifts from the individuals andorg;rnia- 
tions indicated. All other chcmials wcrc of analytical gmdc rnd ob- 
tained from common commcrciul sources. 
Mule C57t3116 mice (Al-AD. Sollcntunu, Swcdcn) weighing uppron- 
imatcly 20 g ill the commcnccmcnt of the cxpcrimcnl wcrc cmploycd 
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Fig. I. deDuvc play of the distribution Of ciII;k\~ in ~hc livers of control mice nnd of mice cxposcd fo clolibrti~c, mfcnopin or WY.14.643. After 
lrcalmcnt of rnimalr. rubcellulx fractionation und arsuy of nIul;lsc 9s dsscribcd in sccaion 2. dcDuvs plots wcrc constructed in the uauul ftlrhion, 
with the fructionr being. from lcfr to righI. the nuclcnr. mitocbondrial. microromnl tmd cy~osolic fr;lctionr. Tbc values arc means for 3 difkrcnt 
irnimlrlr and the bars rcprcrcnt S,D. The rpccific uctiviticr in the whole homogcnrrtc wcrc 25. 41, ill nnd 36 /nnol hydrogen peroxide consumed 
pr mln per mg protein in untrc;ltcd, clolibratc-, nnknopin und WY~l4,643+culcd mice, rcspcclivcly. 
Tilhlc I 
Subccllulilr distribution of culularc activity in mouse liver nficr pcraxiromc prolifcrnlion with clofibrutc. nufcnopin or WY-14,643 
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The vnlucr represent the mcim% + atandurd dcviutions fcr 3 difkrcnt saimalo, 
“PcO.01; “‘PcO.001 comprrcd lo Ihc canlra: group, according to Studem’s r-lest. 
‘Acrivitics crrprcsrcd as mmol hydrogen peroxide conrumcd pr g liver wcrc compared. Corrections were not mndc for incomplcrc rccovcry in the 
subfraclions. 
bMc;lsurcd in the mitochonL:iul rraction, which contuinr 50% of ihc toiul pcroxisomcr, both in control und trcalcd animalr [ 12,131, 
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Fig, 2. Time-course of the incrcascs in proxisomal (MLO) and cy- 
(osolic (MU) w~lnsc tlctivilics in the livxxs of mice cxprcd to clufi- 
bralc in rhcir diet. Al’tcr Ircalmcnt of the rnimulr for diffcrcnt prriruls 
of lime up to 20 days. subccllular frurtionutiun wus performed und 
cahrlusc uctivities in the mitorhondrial (MLO) and hiyh.spccd super- 
nmnt (MLS) fractions assayed as described in srclioa 2. The virlucs 
arc means for 3 diffcrcnl animals und the bars rcprcrnt slrndard 
dcvhtions. 
in this study. The trcatcd animals reccivcd 0.5% (w/w) clofibmtr, 
O.l?S% (w/w) nnfcnopin or O.I2S% (w/w) WY-14.643 mixed with 
powdered srandnrd Irborcltory chow (Ewes. SlklcrUljc. Sweden) for 
4 dnys before sacrifice by cervical dirl_Gon. In one cxpcrimcnt the 
nnimals *erc trcatcd for 20 days whh thr smc doss of clofibrrtc und 
thcrcaftcr allowed to recover for IO days. 
After sacrifice. the liver was rcmovcd and l&d from the pllblad- 
dcr. This risruc was homopnizd in 2 vols. ice-cold 0.3 M surroliC 
using 4 upand-down strokes of it Pot&r-Elvchjcm homogenizer at 
400 rpm. Aflcr dilution to I g liver/S ml with sucrose. JiiTcrcntial 
ccntrifugtion was employed fo subfractionntc this homogcnalc into 
nuclear (600 x p,* pellet), mitochondriul (lO,ooO x g,* pcllc0. micro- 
romul (lOS.000 x gr. pcllct) nnd cylosolic (105,000 x g,* rupsrnalc) 
fntctions, us described and charactcrizcd previously [I 21. 
2.4. Pcrasismul ctdasr 
Pcroxisomal wrul;lac activity WUL uswycd in the mitochondritil frilc- 
tion (which contains SO% of the rolal hcpatic pcroxiFomc% both in 
control and in rrcatcd animals [12.13]) on the buris of spcctropholo- 
metric monitoring of the diruppearancc of M:O: (141. 
2s. Pi??rck 
Protein WBX dctcrmincd by the proccdurc of Lowry nnd coworkers 
[IS], using bovine serum albumin as Ihc standard. 
dcDuvc plots wcrc constructed in the usunl f;lshicn [ 161. 
3. RESULTS AND DISCUSSION 
Table I documents the changes observed in hcpatic 
catalase activity in mouse treated with clofibrate, nafcn- 
opin or WY-14.643. All of these pcroxisomc prolifera- 
tors caused an approximately 2-fold increase in the total 
homogenate and pcroxisomal catalasc activities, but a 
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days after termination f 
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Fig. 3.Timc~urscsofthcrcturnofpcroxisomnl(MW)~ndcytorolic: 
(MLS) ca~alur uctivilics in the llv~lv of mist to control levels aRrr 
tcrminution of exposure 10 clolibntc. After dietary cxperurc of the 
mlrr IO rlofibrutc for 20 dnys und subsqucnt rccovcry for wriou~ 
periods of time, subcclluler fractionation was performsd and calrlooe 
ueivitics in the mit~hondriul (MLO) uncl hi@spccd rupcnisurnt 
(MLS) frxtlons usr;cycd as described in salion 2. The valuer ore 
mcuns for 3 diffcrcnl animals and ~hc brn rcprcscnl SD. 
much more dramatic increase in the corresponding ac- 
tivity rccovcred in the high-speed supcrnatant fraction. 
This much more pronoun& cffcct on the cytosolic 
c;rtalasc results in the rccovcry of 3&359b of the total 
cutalasc in the high-speed supcrnatant after treatment 
with the peroxisomc prolifcrators (Table I). This rcdisl 
tribution of activity is also apparent from the dcDuvc 
plor pr*Qntcd in Fig. 1, where the relative specific activ- 
ity of catulase in the mitochondrial fraction (containing 
50% of the peroxisomcs) isdramatically decreased and 
the arcu under the bar representing the cytosolic frac- 
tion dramatically increased after exposure. 
Fig. 2 illustrates the time-course for the incrsasc in 
pcroxisomal and cytosolic catalasc activities during 
trcatmcnt of miu! with clofibratc for 20 days. It can be 
seen that the maximal incrcasc in the cytosolic activity 
is achieved in about 3 days, whcrcas the increase in 
pcroxisomal catalasc does not even begin until 3 days 
after commencement of treatment and requires about 
10 days to reach the maximal value. 
Fig. 3 shows the time-course for the return of per- 
oxisomal and cytosolic catalase nctivitics to control Icv- 
els after termination of cxposurc to clofibratc for 20 
days. Mere, it is apparent hat the cytosolic activity is 
reduced by about 50% within 2 days of rccovcry and 
returns to control lcvcls within 10 days. The per- 
oxisomal activity, on the other hand, does not begin to 
dccrcasc until at least 2 days after cessation of trcat- 
mcnt, but thereafter eturns to the control level rcla- 
tively rapidly. 
Thus, upon cxposurc of mice to clofibratc the hcpatic 
cytosolic atalasc activity increases prior to the incrcasc 
in pcroxisomal activity and upon termination of this 
cxposurc. the cytosolic activity also dccreascs first. This 
213 
Volume 308, number 2 Ff!BS tET=T’ERS August 1991 
may indicate that the cytosolic uctivity is trunslocatcd 
to pcroxisomcs, P suggestion which is purticularly inax- 
csting in the light of o rcccnt report that the prroxisomcs 
initiully formed in response to trcatmcnt of mice with 
clofibrsrtc luck catalusc [17]. Also of rclcvancc in this 
rcspcct is the report that during pcroxisomal biogcncsis 
in regcncrating liver. the membrane is synthesized first 
and the matrix proteins synthcsizcd und incorporated 
thcrcnftcr [18], In vitro studies on the import of cy- 
tosoliccotalasc from the livers of clofbrntc-trcatcd mice 
into pcroxisomw arc now in progress. 
Arl;rro~~~/zrlpn~rnrrr: Sha e studies wrc supported by granrd from the 
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